Pediatrics, Children’s Hospital of Richmond Virginia Commonwealth University, Richmond, VA
Pediatric Endocrinology, Yale University , New Haven, CT
Pediatric Endocrinology – American Board of PediatricsPediatrics – American Board of Pediatrics
B.S., Major: Biology, Minor: Chemistry, Virginia Commonwealth University, Richmond, VA
D.O., Doctor of Osteopathy, Edward Via College of Osteopathic Medicine, Blacksburg, VA
Attending Physician
Dr. Neha Patel is known for her expertise in type 1 diabetes, specifically technologies. Before coming to CHOP in 2023, she was involved in the initial development and clinical trials of the artificial pancreas while at Yale. She personally knows the difficulties and obstacles of managing this chronic disorder and has come to realize that research provides a path by which optimization of care can be achieved. Based on her experiences, she wishes to commit herself to improving diabetes care, focusing on the application of technologies. One of her prior clinical trials focused on mitigating hypoglycemia during exercise on a closed-loop system, a topic on which she has presented internationally. She has worked on various trials including TrialNet (Pathway to Prevention study - a multi-center research study dedicated to identifying type 1 diabetes antibodies in people with high genetic risk) and the surveillance of COVID-19 in patients with type 1 diabetes.
1. Tallon EM, Ebekozien O, Sanchez J, Staggs VS, Ferro D, McDonough R, Demeterco-Berggren C, Polsky S, Gomez P, Patel N, Prahalad P, Odugbesan O, Mathias P, Lee JM, Smith C, Shyu CR, Clements MA. Impact of diabetes status and related factors on COVID-19-associated hospitalization: A nationwide retrospective cohort study of 116,370 adults with SARS-CoV-2 infection. Diabetes Res Clin Pract. 2022 Nov 15;194:110156. doi: 10.1016/j.diabres.2022.110156. Epub ahead of print. PMID: 36400172; PMCID: PMC9663407.
2. Mistry S, Tonyushkina KN, Benavides VC, Choudhary A, Huerta-Saenz L, Patel NS, Mahmud FH, Libman I, Sperling MA. A Centennial Review of Discoveries and Advances in Diabetes: Children and Youth. Pediatr Diabetes. 2022 Jul 12. doi: 10.1111/pedi.13392. Epub ahead of print. PMID: 35821595.
3. Alonso GT, Ebekozien O, Gallagher MP, Rompicherla S, Lyons SK, Choudhary A, Majidi S, Pinnaro CT, Balachandar S, Gangat M, Curda Roberts AJ, Marks BE, Creo A, Sanchez J, Seeherunvong T, Jimenez-Vega J, Patel NS, Wood JR, Gabriel L, Sumpter KM, Wilkes M, Rapaport R, Cymbaluk A, Wong JC, Sanda S, Albanese-O'neill A. Diabetic ketoacidosis drives COVID-19 related hospitalizations in children with type 1 diabetes. J Diabetes. 2021 Aug;13(8):681-687. doi: 10.1111/1753-0407.13184. PubMed PMID: 33855813; PubMed Central PMCID: PMC8251108.
4. Miller R, Ashraf AP, Gourgari E, Gupta A, Kamboj MK, Kohn B, Lahoti A, Mak D, Mehta S, Mitchell D, Patel N, Raman V, Reynolds DG, Yu C, Krishnan S. SARS-CoV-2 infection and paediatric endocrine disorders: Risks and management considerations. Endocrinol Diabetes Metab. 2021 Jul;4(3):e00262. doi: 10.1002/edm2.262. eCollection 2021 Jul. Review. PubMed PMID: 34268455.
5. Ash GI, Joiner KL, Savoye M, Baker JS, Gerosa J, Kleck E, Patel NS, Sadler LS, Stults-Kolehmainen M, Weinzimer SA, Grey M. Feasibility and safety of a group physical activity program for youth with type 1 diabetes. Pediatr Diabetes. 2019 Jun;20(4):450-459. doi: 10.1111/pedi.12841. PubMed PMID: 30834621; PubMed Central PMCID: PMC6508986.
6. Siebel S, Galderisi A, Patel NS, Carria LR, Tamborlane WV, Sherr JL. Reversal of Ketosis in Type 1 Diabetes Is Not Adversely Affected by SGLT2 Inhibitor Therapy. Diabetes Technol Ther. 2019 Mar;21(3):101-104. doi: 10.1089/dia.2018.0356. PubMed PMID: 30688521; PubMed Central PMCID: PMC6434586.
7. Patel NS, Van Name MA, Cengiz E, Carria LR, Weinzimer SA, Tamborlane WV, Sherr JL. Altered Patterns of Early Metabolic Decompensation in Type 1 Diabetes During Treatment with a SGLT2 Inhibitor: An Insulin Pump Suspension Study. Diabetes Technol Ther. 2017 Nov;19(11):618-622. doi: 10.1089/dia.2017.0267. PubMed PMID: 29068709; PubMed Central PMCID: PMC5689123.
8. Patel NS, Van Name MA, Cengiz E, Carria LR, Tichy EM, Weyman K, Weinzimer SA, Tamborlane WV, Sherr JL. Mitigating Reductions in Glucose During Exercise on Closed-Loop Insulin Delivery: The Ex-Snacks Study. Diabetes Technol Ther. 2016 Dec;18(12):794-799. doi: 10.1089/dia.2016.0311. PubMed PMID: 27996320; PubMed Central PMCID: PMC5178000.
9. Sherr JL, Patel NS, Michaud CI, Palau-Collazo MM, Van Name MA, Tamborlane WV, Cengiz E, Carria LR, Tichy EM, Weinzimer SA. Mitigating Meal-Related Glycemic Excursions in an Insulin-Sparing Manner During Closed-Loop Insulin Delivery: The Beneficial Effects of Adjunctive Pramlintide and Liraglutide. Diabetes Care. 2016 Jul;39(7):1127-34. doi: 10.2337/dc16-0089. PubMed PMID: 27208332; PubMed Central PMCID: PMC4915555.
1. Siebel S, Patel NS, Galderisi A, Carria LR, Tamborlane WV, Sherr J. (July 2018) “Suppression of Ketogenesis in Type 1 Diabetes Is Not Delalyed by SGLT2 Inhibitor Therapy.” 78th Scientific Sessions of the American Diabetes Association, Orlando FL, July 2018.
2. Ash GI, Joiner KL, Savoye M, Baker JS, Gerosa J, Kleck E, Patel NS, Stults-Kolehmainen M, Weinzimer SA. Grey M. “Bright 1 Bodies: Extending the Bright Bodies Family-Based Intensive Lifestyle Therapy to Adolescents with Type 1 Diabetes.” Abstract accepted. Annals of Behavioral Medicine. Vol 52, S281. May 2018.
3. Ash GI, Joiner KL, Savoye M, Baker JS, Gerosa J, Kleck E, Patel NS, Stults-Kolehmainen M, Weinzimer SA. Grey M. “Safety and Health Outcomes of a Physical Activity Program for Adolescents with Type 1 Diabetes.” Accepted for poster presentation, Annual Meeting of the American College of Sports Medicine, Minneapolis, MN, USA. May 2018.
4. Abrosino JM, Weinzimer SA, Tichy E, Steffen A, Finnegan J, Sukumar N, Saxena S, Galderisi A, Vanname MA, Patel NS, Sherr JL, Tamborlane WV, Cengiz E. “Psychosocial Distress Associated with the Added Demands of Managing Type 1 Diabetes during Menstrual Cycles in Female Adolescents and Young Adults.” Accepted for poster presentation, 77th Scientific Sessions of the American Diabetes Association. San Diego, CA. June 2017.
5. Patel, N, Van Name, MA, Carria, L, Cengiz, E, Weinzimer, S, Tamborlane, WV, Sherr, JL. “Altered Patterns of Early Metabolic Decompensation in SGLT2i-Treated T1D after Interruption of Basal Insulin.” Accepted for poster presentation, 77th Scientific Sessions of the American Diabetes Association, San Diego, CA, June 2017
6. Patel, N, Van Name, MA, Carria, L, Cengiz, E, Weinzimer, S, Tamborlane, WV, Sherr, JL. “Safety of SGLT2 Inhibitor Treatment in Type 1 Diabetes: Change in the Pattern of Early Metabolic Decompensation Following Basal Insulin Suspension.” Poster presentation, Automated Technologies and Treatments for Diabetes, Paris, Feb 2017
7. Card, C, Sherr, JL, Cengiz, E, Michaud, CI, Patel, N, Palau-Collazo, MM, Carria, L, Tichy, E,
Tamborlane, WV, Weinzimer, SA. “Influence of glucose setpoint and pre-meal bolus on PID-based closed-loop performance.” Poster presentation, Diabetes Technology Society, Bethesda, MD, Nov 2014
8. Weinzimer, SA, Bitton, G, Grosman, B, Sherr, JL, Michaud, C, Patel, N, Tichy, E, Carria, L, Tamborlane, WV, Cengiz, E. “Effect of an insulin infusion site warming device on performance of a closed-loop system.” Poster presentation, Automated Technologies for the Treatment of Diabetes, Paris, Feb 2015.
9. Cengiz, E, Tamborlane, WV, Sherr, JL, Patel, N, Michaud, C, Tichy, E, Muchmore, D, Wu, W, Carria, L, Loftus, K, Weinzimer, SA. “Recombinant human hyaluronidase use during fully-automated closed-loop (CL) therapy: preliminary results.” Poster presentation, Automated Technologies for the Treatment of Diabetes, Paris, Feb 2015.
Nominated for Longitudinal Course, Women’s Interprofessional Network of the American Diabetes Association
Nominated and Accepted to Association of American Medical Colleges: Early Career Women Faculty Leadership Seminar, Minneapolis, MN
Exceptional Teacher Recognition, Penn State Health, Hershey, PA
Medical Group Dean’s List: Extraordinary Patient Satisfaction, Penn State Health, Hershey, PA
American Diabetes Association Young Investigator Travel Grant Award, Yale University, New Haven, CT
Pediatric Endocrine Society Travel Grant Award, Yale University, New Haven, CT
Endocrine Fellows Foundation Research Grant, Yale University, New Haven, CT
Selected to participate in 1st Annual ESPE Diabetes/Obesity School, Jaffa, Israel
Selected to participate in PES Fellows’ Science School, Warrenton, VA
Recipient of Virginia College of Osteopathic Medicine (VCOM) Excellence in Pediatrics Award, VCOM, Blacksburg, VA
Recipient of VCOM Community Service Award, VCOM, Blacksburg, VA
Health Focus of Southwest Virginia Scholar, VCOM, Blacksburg, VA
Lewis Gale Medical Center Scholar, VCOM, Blacksburg, VA
Phi Kappa Phi Honor, Virginia Commonwealth University, Richmond, VA
Phi Eta Sigma National Honor, Virginia Commonwealth University, Richmond, VA
Outstanding Scholastic Accomplishment, Virginia Commonwealth University, Richmond, VA
National Society of Collegiate Scholars, Virginia Commonwealth University, Richmond, VA
Member of Virginia Commonwealth University Honors Program, Virginia Commonwealth University, Richmond, VA
Virginia Commonwealth University Dean’s List, Virginia Commonwealth University, Richmond, VA
2018-2023 Director of Children’s Diabetes Program at Penn State
2022 – Present Association of American Medical Colleges, Group on Women in Medicine
and Science
2021 - Present Endocrine Society
2021 - Present International Society for Pediatric and Adolescent Diabetes
2017 - Present Pennsylvania American Osteopathic Association
2014 - Present European Society for Paediatric Endocrinology
2013 - Present Pediatric Endocrine Society, Drug and Therapeutics/Rare Disease
Committee & Diabetes SIG
2013 - Present American Diabetes Association, general member
2009 - Present American Academy of Pediatricians, general member